International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 140-144 doi: 10.5281/zenodo.16434437
Original Article
Functional Outcome in Traumatic Cervical Subluxation Treated with Anterior Cervical Discectomy and Fusion: A Single-Center Experience
 ,
 ,
 ,
 ,
 ,
 ,
Published
July 26, 2025
Abstract

Background: Traumatic cervical subluxation is a significant cause of neurological deficits, often requiring surgical intervention. This study evaluates the neurological improvement and functional outcomes in patients with traumatic cervical subluxation treated with anterior cervical discectomy and fusion (ACDF).

Methods: A prospective single-center study was conducted at Government Vellore Medical College Hospital, including 36 patients aged over 18 years with traumatic cervical subluxation confirmed by MRI and treated with ACDF. Exclusion criteria included active cervical infection, neoplasia, metastasis, failed previous cervical surgery, or neurovascular injury. Demographic data, preoperative and postoperative neurological status (ASIA scale), radiographic findings, and functional outcomes (Nurick grades) were analyzed over a 6-month follow-up.

Results: Of the 36 patients, 80.6% showed functional improvement: 16.7% achieved a cure (Nurick grade 0 or 1), 36.1% had good outcomes (two-grade improvement), 27.8% had fair outcomes (one-grade improvement), and 19.4% had poor outcomes (no change). ASIA scale improvement occurred in 34.5% of patients, with ASIA A injuries showing the least recovery (28.6%). The 30-day mortality rate was 8.6%, primarily due to respiratory failure in ASIA A patients.

Conclusion: ACDF significantly improved functional outcomes in patients with traumatic cervical subluxation, particularly those without respiratory distress or comorbidities. Early surgical intervention is recommended for poor-grade cases

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1044 Views
209 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved